A practical reference on secretagogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Quality control for research-grade ipamorelin is not governed by a single harmonized pharmacopeial monograph, so certificates of analysis vary between suppliers. Common tests include appearance, solubility, water content, peptide content by quantitative amino acid analysis, and residual counterion measurement. Independent verification by an outside laboratory is often used to confirm identity and purity claims. Salt form, counterion content, and residual solvent levels are frequently unspecified, which complicates direct comparison between lots and leaves reproducibility partly unresolved.
Identity and purity assessment of ipamorelin relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength where the peptide backbone absorbs. Mass confirmation is typically obtained by electrospray ionization mass spectrometry or by liquid chromatography coupled to mass spectrometry, comparing the observed mass with the calculated value. Amino acid analysis and peptide mapping after enzymatic digestion can confirm the sequence. Impurity profiles include deletion peptides, truncated fragments, and oxidation products, reported as relative area percentages.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
| Property | Value | Notes |
|---|---|---|
| Appearance | White lyophilized powder | Typical form for research-grade material |
| Solubility | Soluble in water | Aqueous buffer also used |
| Typical storage | -20 degrees Celsius or below | Desiccated and protected from light |
| Primary analytical method | RP-HPLC with UV detection | Purity expressed as relative peak area |
| Identity confirmation | ESI-MS or LC-MS | Compared with calculated 711.85 Da |
Most published work on ipamorelin comes from rodent studies and small early-phase human trials. Subcutaneous and intravenous routes have been used, while oral delivery is limited by poor absorption and rapid breakdown in the gut. The reported plasma half-life is short, on the order of two hours, and varies with species and assay method. Whether chronic use produces meaningful clinical benefit remains unresolved, and long-term safety data in humans are sparse. No major regulatory agency has approved the compound as a therapeutic drug.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues that resist enzymatic breakdown. Researchers at Novo Nordisk described the compound in the 1990s while searching for agents that release growth hormone with fewer side effects than earlier secretagogues. The molecule acts as an agonist at the ghrelin receptor, also called GHS-R1a, which is expressed in the pituitary and in several peripheral tissues.
=== Biogene Amine === Nachgewiesen wurden Histamin, Serotonin und Acetylcholin, letzteres mit einem Anteil von 5 Prozent der Trockenmasse. Vermutlich nicht der längere Stachel der Hornisse, sondern Acetylcholin, das weder im Bienengift noch im Hummel- oder Wespengift vorkommt, bewirkt bei der von einer Hornisse gestochenen Person ein höheres Schmerzempfinden. Im Gift der Orientalischen Hornisse (Vespa orientalis) wurden auch beträchtliche Mengen an Noradrenalin, Adrenalin und Dopamin gefunden.
Mastoparane, Peptide, die Mastzellen degranulieren, wobei Mastoparan-1 aber auch antibakterielle Eigenschaften gegen Gram-negative und Gram-positive Bakterien besitzt, die unter anderem auf eine Zerstörung der Bakterienmembran und eine dosisabhängige Neutralisierung von Lipopolysacchariden zurückzuführen sein dürfte. Crabrolin Die Hauptbestandteile des Giftes der Osteuropäischen Hornisse Vespa orientalis sind die hochmolekularen Proteine Orientotoxin-1 und Orientotoxin-2 sowie die niedermolekularen, Histamin freisetzenden Peptide HR-1, HR-2 und HR-3.
=== Enzyme === Phospholipase A und -B, Hyaluronidase sowie saure, alkalische und neutrale DNasen und Proteasen fallen in diese Gruppe; zusammen mit dem Antigen V sind diese Bestandteile des Giftes als Hauptallergene für die auch nach wiederholten Hornissenstichen auftretende Insektengiftallergie verantwortlich zu machen, unter der ungefähr 2 bis 3 Prozent der Bevölkerung zu leiden haben, die allerdings völlig losgelöst von einer Toxinwirkung betrachtet werden muss. Das Allergenspektrum der Hornissen entspricht weitgehend dem der Wespen, so dass Allergiker auch ähnlich behandelt werden können.
Als Aminosäuresequenz, auch Peptidsequenz oder Proteinsequenz, wird die Abfolge der verschiedenen Aminosäuren in einem Peptid bezeichnet, insbesondere der Polypeptidkette eines Proteins. Die Aminosäuresequenz gibt Auskunft darüber, aus welchen Aminosäuren ein Peptid oder Protein aufgebaut ist und in welcher Reihenfolge die einzelnen Aminosäure-Bausteine durch Peptidbindungen miteinander verknüpft sind; sie stellt die Primärstruktur eines Proteins dar.
Sources: de.wikipedia.org
The standard approach is reversed-phase high-performance liquid chromatography, with purity reported as the relative area of the main peak. Ultraviolet detection near 214 nanometers is typical for peptides. Mass spectrometry is added to confirm identity rather than to quantify purity.
Once dissolved, the peptide is exposed to hydrolysis, oxidation, and aggregation pathways that are slowed in the dry state. Freeze-thaw cycling and warm storage accelerate these losses. Keeping the lyophilized powder cold and dry is the usual way to limit degradation.
No single pharmacopeial monograph covers ipamorelin, so suppliers apply their own specifications. Certificates of analysis therefore differ in the tests performed and the limits set. Independent laboratory verification is often needed to compare materials from different sources.
Ipamorelin is a synthetic pentapeptide that stimulates growth hormone release by activating the ghrelin receptor. It is handled as a research tool rather than as a licensed therapeutic product. Its short chain length makes it comparatively simple to synthesize and analyze.